OraSure Technologies | OSUR - 营业费用



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 283.7M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


营业费用 更改 日
Agilent USD 1.44B 9M 2026-03
AngioDynamics USD 81.95M 1.68M 2025-09
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 2.84B 1.96B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Illumina USD 899M 47M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 646.2M 1.21B 2026-06
Repligen USD 183M 8.72M 2026-06
Revvity USD 603.55M 24.8M 2026-06
STAAR Surgical USD 83.43M 7.32M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Trinity Biotech USD 12.38M 2.44M 2025-12
Waters USD 527M 592M 2026-06